Morningstar Investment Management’s Verona Pharma VRNA Stock Holding History

Morningstar Investment Management’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-20,084	Closed	-$2.14M	–	469
2025 Q3	$2.14M	Buy	+20,084	New	+$2.1M	0.08%	235

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Morningstar Investment Management's VRNA Position: Q4 2025 in Review

Morningstar Investment Management sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 20,084 shares — an estimated $2.14M sold.

Morningstar Investment Management first reported a position in VRNA in Q3 2025 and held it in 1 quarter. The position peaked at $2.14M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Morningstar Investment Management reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Morningstar Investment Management sold 20,084 Verona Pharma shares in Q4 2025, an estimated $2.14M.
Morningstar Investment Management first reported a position in Verona Pharma in Q3 2025 and held it in 1 quarter.
Morningstar Investment Management's Verona Pharma position peaked at $2.14M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Morningstar Investment Management's 13F filing for Q4 2025, filed 9 Feb 2026.